DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Election/Restrictions
Applicant's election with traverse of Species E, claims 1, 8-14, 17-25 in the reply filed on 8/19/26 is acknowledged. Species D, F, G, and H are rejoined.
Regarding the election, for clarity of record, Examiner notes Applicant elected Species E, sound processor for impulse frequency, claims 9-10 (see Page 5, five lines from bottom). However, Applicant’s comments on the election of Species E as the “second processor for impulse parameter adjustment, e.g. claims 9-12”, would normally be considered nonresponsive, because it groups together Species E, F, and G, which were identified in the previous restriction requirement as patentably distinct species (MPEP § 821.03). Applicant is required to elect a single (i.e. only one) species. No groupings of patentably indistinct species were identified in the restriction requirement. Applicant’s own grouping putting Species E, F, and G together into one group amounts to an argument that those claims are all generic, and would thus constitute a nonresponsive reply. However, to expedite prosecution, and in light of the prior art, Species D, F, G, and H are rejoined.
Applicant asserts the various parameter adjustments are not structurally distinct species because it is merely a software distinction on identical hardware. This is not persuasive because the different parameters require different hardware/software configurations. For example, a reference disclosing only frequency adjustment would not read on a claim reciting a waveform adjustment. Nevertheless, these particular species have been rejoined in light of the prior art.
Applicant asserts mutual exclusivity means that the presence of one species must preclude the presence of another, and asserts that the secondary circuit board can simultaneously include all the features at once. This is not persuasive because the claims are indeed mutually exclusive because they do not overlap in scope.
Applicant further asserts the species merely describe different functions, and are not structurally distinct because they use the same secondary circuit board. This is not persuasive because the different functions require different hardware/software configurations. For example, a reference disclosing only a secondary circuit for communications would not read on a charging circuit.
Applicant further asserts there is no search burden. However, search burden has already been established in the previous action. Each species requires a separate search. For example, a reference disclosing only a secondary circuit with display adjustment would not read on a secondary circuit for authorization.
The requirement is still deemed proper and is therefore made FINAL.
Claims 2-7, 15, 16 withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected species, there being no allowable generic or linking claim. Applicant timely traversed the restriction (election) requirement in the reply filed on 8/19/26.
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 1, 8-14, 17-25 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
Claim 1, line 3: “the target location” lacks proper antecedent basis.
Claim 1, last line: “the main circuit board” lacks proper antecedent basis. Examiner suggests reciting the “primary” circuit board.
Claim 19: Unclear what is the delineation between the energy source and the signal generator, since the energy source was already previously recited as being configured to generate the electrical impulse.
Claim Rejections - 35 USC § 103
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention.
Claim(s) 1, 8-14, 17-25 is/are rejected under 35 U.S.C. 103 as being unpatentable over Staats (US 2022/0323745) in view of Brodard (US 4,919,139).
PNG
media_image1.png
292
413
media_image1.png
Greyscale
Regarding claim 1, Staats discloses substantially the same invention as claimed (Figure 1 shown above for example), including a system for stimulating a nerve within a user (Figure 1), the system comprising: a stimulator comprising an electrode configured for contacting the outer skin surface at, or near the target location (Figure 1); an energy source coupled to the stimulator and configured to generate at least one electrical impulse and to transmit the at least one electrical impulse transcutaneously from the electrode through the outer skin surface of the user to a selected nerve in the user adjacent to, or near, the target location (Figure 1); wherein the energy source comprises a primary circuit board that includes a processor and a computer-readable data storage device storing program instructions that, when executed by the processor, the program instructions generate the electrical impulse (Figure 1: 330).
Further regarding claim 1, Staats does not disclose a removable secondary circuit board as recited. However, Brodard teaches a secondary circuit board removably coupled to the main circuit board (Figure 1: removable program cartridge 6; abstract), in order to easily load new therapy programs. Therefore, it would have been obvious to one with ordinary skill in the art before the effective filing date of the claimed invention to modify Staats as taught by Brodard to include a removable secondary circuit board as recited, in order to easily load new therapy programs.
Regarding claims 8-14, the removable program cartridge of Brodard includes parameter adjustments as recited (Col. 4, line 65 to Col. 5, line 5).
Regarding claims 17-19, Staats discloses a housing, electrode, and signal generator as recited (Figure 1).
Regarding claims 20-23, Staats discloses the same stimulation parameters as recited (Paragraph 24; Figures 2B-C).
Regarding claim 24, Staats discloses the vagus nerve as recited (abstract).
Regarding claim 25, Staats discloses contacting a neck as recited (Figure 7).
Double Patenting
The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969).
A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b).
The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13.
The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer.
Claims 1, 8, 9 provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 20, 22, 23, 46, 48, 49 of copending Application No. 18897210 (reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because the claims of the copending application anticipate the claims of the instant application.
This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented.
Instant application
Copending application
1
20, 46
8
22, 48
9
23, 49
Claims 1, 10-14, 17-25 provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1, 11-20, 23, 24, 38-46, 49 of copending Application No. 18897210 in view of Brodard (US 4,919,139). These copending application claims recite substantially the same subject matter except for the removable secondary circuit board. However, Brodard teaches a secondary circuit board removably coupled to the main circuit board (Figure 1: removable program cartridge 6; abstract), in order to easily load new therapy programs, including various parameter adjustments (Col. 4, line 65 to Col. 5, line 5). Therefore, it would have been obvious to one with ordinary skill in the art before the effective filing date of the claimed invention to modify the copending application as taught by Brodard to include a removable secondary circuit board as recited, in order to easily load new therapy programs.
This is a provisional nonstatutory double patenting rejection.
Instant application
Copending application
1, 10-14
1, 20, 23, 24, 46, 49
17
11
18
12, 38
19
13, 39
20
14, 40
21
15, 41
22
16, 42
23
17, 43
24
18, 44
25
19, 45
Conclusion
The prior art made of record and not relied upon is considered pertinent to applicant's disclosure.
Simon (US 2023/0059748) shows a nerve stimulation device.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to Eugene T Wu whose telephone number is (571)270-5053. The examiner can normally be reached M-F 8am-5pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Niketa Patel can be reached at 571-272-4156. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/Eugene T Wu/Primary Examiner, Art Unit 3796